A Study in Non-squamous Non Small Cell Lung Cancer in Asian Patients
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
To investigate efficacy and safety of the combination with pemetrexed plus carboplatin,
followed by pemetrexed in patients with advanced nonsquamous Non Small Cell Lung Cancer
(NSCLC) who receive at least one dose of the induction therapy.